Advances in Chemistry

Advances in Chemistry / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 834641 |

Hamid Beyzaei, Reza Aryan, Zahra Keshtegar, "Synthesis of New Imidazolidine and Tetrahydropyrimidine Derivatives", Advances in Chemistry, vol. 2014, Article ID 834641, 4 pages, 2014.

Synthesis of New Imidazolidine and Tetrahydropyrimidine Derivatives

Academic Editor: Hideaki Shirota
Received04 May 2014
Accepted23 Jun 2014
Published14 Jul 2014


Synthesis of new imidazolidine and tetrahydropyrimidine derivatives 3a, b and 4a–c as cyclic 1,3-diamines under two reaction conditions (A and B) is described. Under reaction conditions-A, a suspension of (E)-2-cyano-2-(oxazolidin-2-ylidene)ethanethioamide 1 (1 eq.) and diaminoalkanes 2a–e (2 eq.) in absolute ethanol is heated under reflux for 16–22 h to afford 3a, b and 4a–c. Alternatively, under reaction conditions-B, a solution of thioamide 1 (1 eq.) in diaminoalkanes 2a–e (3 eq.) is stirred under solvent-free conditions at room temperature for 3 days to give desired products. Reaction conditions-A for having higher yields, shorter reaction times, and required less diamines is more effective than reaction conditions-B. Oxazolidine ring opening is observed by reacting compound 1 with all of the diamines 2a–e, but the thioamide group only reacts with nonbulky diamines 2a, b. The chemical structures of novel compounds were confirmed by 1H NMR, 13C NMR, elemental analysis, and FT-IR spectrometry.

1. Introduction

Imidazolidines (tetrahydroimidazoles) are important building blocks in biologically active compounds [1] and carriers of pharmacologically active carbonyl compounds [2]. They have been reported to have important biological activities including, for example, 2-[(arylmethoxy) imino]imidazolidines as potential α-adrenergic receptor agonist [3], bisimidazolidines and 1,3-disubstituted imidazolidines as antimicrobial [4], 5-(4-chloro or fluoro-benzylidene-3-(4-nitrebenzyl)-4-thioxo-imidazolidin-2-one as antiparasitic [5], sulfonyliminoimidazolidines as oral hypoglycaemic [6], imidazolidin-2,4-diones, 2-thioxoimidazolidin-4-ones, 5-cycloalkylidene-hydantoins, and 5-cycloalkylidene-thiohydantoins as antiarrhythmic and anticonvulsant [7, 8], 1,3-dibenzyl-2-arylimidazolidine as anti-inflammatory [9], N,N′-di-aryl-methyl-2-(4-diethylamino phenyl) tetrahydroimidazoles and N,N′-di-4-diethylamino benzyl-2-(aryl) tetrahydroimidazoles as analgesic [10]. They have also been utilized as a versatile template for the synthesis of compounds with potential cyclooxygenase-2 inhibition activity [11] and termed as a promising group of NSAIDs with potential anti-inflammatory activities [9].

The pyrimidine fragment is present in various biologically active compounds, many of which have been found to be used in medical practice [12, 13]. Recently, much attention has been paid to derivatives of pyrimidine, including their hydrogenation products. This class of compounds displays wide ranges of biological and pharmacological properties such as anti-inflammatory [14], analgesic [15], antitumor [16], antidepressant [17], antibacterial, antifungal, and antitubercular effects [1820].

The application of these compounds in pharmaceutical field prompted us to synthesize some new imidazolidines and tetrahydropyrimidines under two reaction conditions. These synthesized compounds are characterized by NMR, IR spectral data, and elemental analysis.

2. Results and Discussion

Cyclic 1,3-diamines 3a, b and 4a–c were prepared under two reaction conditions. Under reaction conditions-A, a mixture of (E)-2-cyano-2-(oxazolidin-2-ylidene)ethanethioamide 1 (1 eq.) and appropriate diaminoalkanes 2a–e (2 eq.) in absolute ethanol are refluxed for 16–22 h to afford the solid products 3a, b and 4a–c (Scheme 1). Under reaction conditions-B, similar treatment of the thioamide 1 (1 eq.) with appropriate diaminoalkanes 2a–e (3 eq.) under solvent-free conditions at room temperature for 3 days afforded the desired products. The yields of the products obtained are depicted in Table 1.

EntryProducts DiaminoalkaneTime (h)aYield (%)


Only for reaction conditions-A.

A comparison between the results obtained from both reaction conditions leads us to the conclusion that reaction conditions-A is from 65% to 77% as efficient as reaction conditions-B, also the former has shorter reaction times and required less diamines but requires a supply of heat. It is worth noting that oxazolidine ring opening is observed by reacting compound 1 with all of the diamines 2a–e, but the thioamide group only reacts with nonbulky diamines 2a, b. This is probably due to the rigid structure of compound 1 that prevents the effective interaction with bulky diamines 2c–e.

A plausible mechanism is depicted for the formation of these compounds (Scheme 2). As depicted in Scheme 2, intermediates 3a, b and 4a–c probably were produced from two successive Michael substitution reaction thioamide 1 and diaminoalkanes 2a–e. It predicts that during adding amine to oxazolidine ring, the C–O bond breaks faster than the C–N bond because alkoxy is a better leaving group than amine. Note that in this multistep synthesis, the likely key intermediates 3a, b were not isolated except for intermediates 4a–c which were isolated and their structures identified by spectral analysis. When intermediates 3a, b were treated with diaminoalkanes 2a, b, amidines 4a, b that are produced as intermediates followed by a ring closure to 3a, b.


The structural assignments of compounds 3a, b and 4a–c were based on their analytical and spectral data. The 1H NMR spectra of compounds 3ae showed broad signals due to –NH– groups within δ = 7.70–9.51 ppm region. The 13C NMR spectra of the products exhibited signals within δ = 27–65, 117–119, 157–166 ppm regions attributed to the N≡C–C=C–, –C≡N, N≡C–C=C– carbons, respectively. The FT-IR spectra of 3a, b and 4a–c in KBr disk showed the absorption bands within ν = 3273–3311 cm−1 corresponding to –NH– groups, within ν = 2170–2187 cm−1 belonging to nitrile groups and within ν = 1589–1688 cm−1 attributed to the –C=C– exocyclic bonds. All this evidence plus microanalytical data strongly supports the formation of all products.

3. Materials and Methods

3.1. Materials

Melting points were recorded on a Kruss type KSP1N melting point meter and are uncorrected. The IR spectra of products 3a, b and 4a–c were determined using KBr disks with Bruker Tensor-27 FT-IR spectrometer and only major absorptions are listed. The 1H and 13C NMR spectra of DMSO-d6 solutions were recorded on a Bruker FT-NMR Ultra Shield-400 spectrometer (400 and 100 MHz, resp.) with residual protons of the solvent as internal standard (2.50 ppm for 1H and 39.48 ppm for 13C). Elemental analyses were performed on a Thermo Finnigan Flash EA microanalyzer. Monitoring of the progress of reactions and the purity of the products were effected by TLC on alufoil plates precoated with silica gel (60, Merck); eluent was CHCl3-CH3OH, 9 : 1, visualization with I2 vapor. Compound 1 was obtained according to the published method [21].

3.2. Methods
3.2.1. General Procedure for the Synthesis of Cyclic 1,3-diamines (3a, b and 4a–c)

Reaction conditions-A. A suspension of (E)-2-cyano-2-(oxazolidin-2-ylidene)ethanethioamide 1 (0.845 g, 5 mmol) and diaminoalkanes 2a–e (10 mmol) in absolute ethanol (10 mL) is heated under reflux for 16–22 h. The reaction mixture is treated with 2-propanol (10 mL), refrigerated overnight, filtered, and washed with 2-propano1; the residual products are recrystallized from methanol to give 3a, b and 4a–c.

Reaction conditions-B. A solution of (E)-2-cyano-2-(oxazolidin-2-ylidene)ethanethioamide 1 (0.845 g, 5 mmol) in diaminoalkanes 2a–e (15 mmol) is stirred at room temperature for 3 days. Excess diamines are then evaporated in vacuo and the residual products are recrystallized from methanol.

4. Data for Compounds

2-(4,5-Dihydro-1H-imidazol-2-yl)-2-(imidazolidin-2-ylidene)acetonitrile 3a . White needles, mp 218-219°C; FT-IR,ν, cm−1: 3280 (broad, medium, –NH–), 2170 (strong, sharp, –C≡N), and 1688 (strong, sharp, –C=C–); 1H NMR, δ, ppm: 3.55 (s, 8H, –CH2–); 8.21 (b, 3H, –NH–, D2O exchangeable); 13C NMR, δ, ppm: 27.8 (N≡C–C=C–), 43.7 (–CH2–), 117.8 (–C≡N), and 166.5 (N≡C–C=C–). Anal. Calcd. for C8H11N5 (177) C 54.22; H 6.26; N 39.52%, Found: C 54.11; H 6.34; N 39.55.

2-(Tetrahydropyrimidin-2(1H)-ylidene)-2-(1,4,5,6-tetrahydropyrimidin-2-yl)acetonitrile 3b. White needles, mp 209–210°C; FT-IR, ν, cm−1: 3286 (broad, medium, –NH–), 2171 (strong, sharp, –C≡N), and 1688 (strong, sharp, –C=C–); 1H NMR, δ, ppm (J, Hz): 1.77 (q, 4H, J = 5.5, –NHCH2CH2–), 3.18 (t, 8H, J = 5.5, –NHCH2–), and 7.70 (b, 3H, –NH–, D2O exchangeable); 13C NMR, δ, ppm: 19.6 (–NHCH2CH2–), 29.2 (N≡C–C=C–), 38.6 (–NHCH2), and 118.7 (–C≡N); 159.3 (N≡C–C=C–). Anal. Calcd. for C10H15N5 (205) C 58.51; H 7.37; N 34.12%, Found: C 58.53; H 7.27; N 34.20.

2-Cyano-2-(5,5-dimethyltetrahydropyrimidin-2(1H)-ylidene)ethanethioamide 4a. White needles, mp 216–218°C; FT-IR, ν, cm−1: 3416 (broad, medium, –NH2), 3311 (broad, medium, –NH–), 2175 (strong, sharp, –C≡N), and 1615 (strong, sharp, –C=C–); 1H NMR, δ, ppm (J, Hz): 0.95 (s, 6H, –CH3), 3.00 (d, 4H, J = 2.2, –CH2–), 7.27 (b, 2H, –NH2, D2O exchangeable), and 9.51 (b, 2H, –NH–, D2O exchangeable); 13C NMR, δ, ppm: 23.5 (–CH3), 25.0 (–C(CH3)2–), 49.2 (–CH2–), 65.0 (N≡C–C=C–), 119.4 (–C≡N), 157.1 (N≡C–C=C–), and 186.7 (–C=S). Anal. Calcd. for C9H14N4S (210) C 51.40; H 6.71; N 26.64; S 15.24%, Found: C 51.35; H 6.78; N 26.72; S 15.15.

(Z,E)-2-Cyano-2-(4-methylimidazolidin-2-ylidene)ethanethioamide 4b . Yellow needles, mp 189-190°C; FT-IR, ν, cm−1: 3422 (broad, medium, –NH2), 3282 (broad, medium, –NH–), 2182 (strong, sharp, –C≡N), and 1626 (strong, sharp, –C=C–); 1H NMR, δ, ppm (J, Hz): 1.21 (d, 3H, J = 6.2, –CH3), 3.18, 3.74 (dd, 1H, J = 2.3, J = 7.5, t, 1H, J = 9.7, –CH2–); 4.05 (m, 1H, –CHCH3), 7.29 (b, 2H, –NH2, D2O exchangeable), and 9.13 (b, 2H, –NH–, D2O exchangeable). 13C NMR, δ, ppm: 20.4 (–CH3), 50.2 (–CH2–), 51.2 (–CHCH3), 63.0 (N≡C–C=C–), 118.9 (–C≡N), 164.3 (N≡C–C=C–), and 188.7 (–C=S). Anal. Calcd. for C7H10N4S (182) C 46.13; H 5.53; N 30.74; S 17.59%, Found: C 46.08; H 5.61; N 30.81; S 17.50.

2-Cyano-2-(octahydro-2H-benzo[d]imidazol-2-ylidene)ethanethioamide 4c . Brown needles, mp 238–240°C; FT-IR, ν, cm−1: 3418 (broad, medium, –NH2), 3273 (broad, medium, –NH–), 2187 (strong, sharp, –C≡N), and 1589 (strong, sharp, –C=C); 1H NMR, δ, ppm (J, Hz): 1.28–1.56 (m, 4H, –CHCH2CH2–), 1.64–1.74, 2.12 (m, 2H, d, 2H, J = 11.0, –CHCH2CH2–), 3.07, 3.82 (m, 1H, m, 1H, –NHCH–), 7.63 (b, 2H, –NH2, D2O exchangeable, 54.0 (NHCH), 62.5 (N≡C–C=C–), 118.5 (–C≡N), 165.2 (N≡C–C=C–), and 189.0 (–C=S). Anal. Calcd. for C10H14N4S (222) C 54.03; H 6.35; N 25.20; S 14.42%, Found: C 54.10; H 6.44; N 25.12; S 14.34.

5. Conclusion

In summary, several new imidazolidines and tetrahydropyrimidines have been synthesized from the reaction of a single thioamide with several various diaminoalkanes. On the basis of our previously reported work [21], the thioamide itself was synthesized in a regioselective manner from functionalized oxazolidine with phosphorus pentasulfide.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors would like to thank Mrs. Marzieh Akbari for recording spectral NMR analyses.


  1. J. Chang-Fong, K. Benamour, B. Szymonski, F. Thomasson, J. Morand, and M. Cussac, “Synthesis and α-adrenergic binding ligand affinities of 2- iminoimidazolidine derivatives,” Chemical and Pharmaceutical Bulletin, vol. 48, no. 5, pp. 729–733, 2000. View at: Publisher Site | Google Scholar
  2. S. S. Szinai, G. Crank, and D. R. K. Harding, “Perfluoroalkyl carbonyl compounds. 1. Perfluoroaldehyde and perfluorocarboxylic acid derivatives,” Journal of Medicinal Chemistry, vol. 13, no. 6, pp. 1212–1215, 1970. View at: Publisher Site | Google Scholar
  3. J. Sa̧czewski, A. L. Hudson, and A. Rybczyńska, “2-[(arylmethoxy)imino]imidazolidines with potential biological activities,” Acta Poloniae Pharmaceutica—Drug Research, vol. 66, no. 6, pp. 671–680, 2009. View at: Google Scholar
  4. M. C. Caterina, I. A. Perillo, L. Boiani et al., “Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships,” Bioorganic and Medicinal Chemistry, vol. 16, no. 5, pp. 2226–2234, 2008. View at: Publisher Site | Google Scholar
  5. J. K. D. A. L. Neves, S. P. S. Botelho, C. M. L. de Melo et al., “Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni,” Parasitology Research, vol. 107, no. 3, pp. 531–538, 2010. View at: Publisher Site | Google Scholar
  6. F. Marki, O. Buch, and A. Delini-Stula, “Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-{p-[2-(crotonylamino)-ethyl]-phenylsulfonyl}-3-cyclohexyl-1-2-imino-imi dazolidine (CGP 11 112),” Arzneimittel-Forschung, vol. 34, no. 3, pp. 247–252, 1984. View at: Google Scholar
  7. J. A. de Sousa Luis, J. M. B. Filho, B. F. Lira et al., “Synthesis of new imidazolidin-2,4-dione and 2-thioxoimidazolidin-4-ones viaC-phenylglycine derivatives,” Molecules, vol. 15, no. 1, pp. 128–137, 2010. View at: Publisher Site | Google Scholar
  8. M. H. Rossi and R. Zelnik, “Contribution to the chemistry of imidazolidinediones—synthesis of ciclanylidene-hydantoins,” Arquivos do Instituto Biológico, vol. 67, no. 1, pp. 125–130, 2000. View at: Google Scholar
  9. M. S. Y. Khan and G. Chawla, “Tetrahydroimidazoles: a promising group of expected NSAIDS-their synthesis and antiinflammatory activity,” Indian Journal of Chemistry B: Organic and Medicinal Chemistry, vol. 41, no. 3, pp. 653–663, 2002. View at: Google Scholar
  10. V. Sharma and M. S. Y. Khan, “Synthesis of novel tetrahydroimidazole derivatives and studies for their biological properties,” European Journal of Medicinal Chemistry, vol. 36, no. 7-8, pp. 651–658, 2001. View at: Publisher Site | Google Scholar
  11. M. V. Patel, R. Bell, S. Majest, R. Henry, and T. Kolasa, “Synthesis of 4,5-Diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors,” The Journal of Organic Chemistry, vol. 69, no. 21, pp. 7058–7065, 2004. View at: Publisher Site | Google Scholar
  12. M. D. Mashkovskii, Medicinals, Part 1, p. 736, Part 2, p. 688, Meditsina, Moscow, Russia, 1993, (Russian).
  13. N. B. Nikolaeva, Ed., Medicinal Products from Foreign Firms in Russia (in Russian), Astrafarmservis, Moscow, Russia, 1993.
  14. S. N. Mokale, S. S. Shinde, R. D. Elgire, J. N. Sangshetti, and D. B. Shinde, “Synthesis and anti-inflammatory activity of some 3-(4,6-disubtituted-2-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl) propanoic acid derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 15, pp. 4424–4426, 2010. View at: Google Scholar
  15. N. Arora and S. N. Pandeya, “Synthesis and analgesic activity of novel pyrimidine derivatives,” International Journal of Pharmaceutical Sciences Review and Research, vol. 11, no. 1, pp. 48–52, 2011. View at: Google Scholar
  16. J. Yuan, X. Cai, D. Chen, and M. Hu, “Synthesis, structure analysis, and antitumor activity of (R)-2,4-dioxo-5-fluoro-1-[1-(methoxycarbonyl) ethylaminocarbonylmethyl]-1,2,3,4- tetrahydropyrimidine,” Chinese Journal of Chemistry, vol. 25, no. 3, pp. 417–421, 2007. View at: Publisher Site | Google Scholar
  17. K. Weinhardt, M. B. Wallach, and M. Marx, “Synthesis and antidepressant profiles of phenyl-substituted 2-amino- and 2-[(alkoxycarbonyl)amino]-1,4,5,6-tetrahydropyrimidines,” Journal of Medicinal Chemistry, vol. 28, no. 6, pp. 694–698, 1985. View at: Publisher Site | Google Scholar
  18. H. R. Champaneri, S. R. Modi, and H. B. Naik, “Studies on pyrimidines , part II: synthesis and antibacterial activity of 7-(2'-hydroxy-5'-methylphen-1'yl)-2-aceyl-5-substituted phenyl-3-oxo-2,3,4,4-tetrahydeothiazolo (3,2-a)-pyrimidines,” Asian Journal of Chemistry, vol. 6, no. 3, pp. 737–738, 1994. View at: Google Scholar
  19. K. Satyavathi, T. Naga Ravi Kiran, P. Bhoja Raju, and M. Sharmila, “Synthesis and screening of 3-formyl-2-thio-1,2,3,4-tetrahydro pyrimidine analogues as antibacterial agents,” Asian Journal of Chemistry, vol. 22, no. 7, pp. 5182–5186, 2010. View at: Google Scholar
  20. T. N. Akhaja and J. P. Raval, “Design, synthesis, in vitro evaluation of tetrahydropyrimidine-isatin hybrids as potential antibacterial, antifungal and anti-tubercular agents,” Chinese Chemical Letters, vol. 23, no. 4, pp. 446–449, 2012. View at: Publisher Site | Google Scholar
  21. M. Bakavoli, H. Beyzaei, M. Rahimizadeh, and H. Eshghi, “Regioselective synthesis of new 2-(E)-cyano(oxazolidin-2-ylidene)thiazoles,” European Journal of Chemistry, vol. 2, no. 3, pp. 356–358, 2011. View at: Google Scholar

Copyright © 2014 Hamid Beyzaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.